申请人:Kitamura Shuji
公开号:US20120065196A1
公开(公告)日:2012-03-15
The present invention provides compounds represented by the formula (Ie):
and the formula (If):
wherein each symbol is as defined in the specification.
According to the present invention, these compounds have a DGAT inhibitory activity and are useful for the prophylaxis, treatment or improvement of diseases or pathologies caused by high expression or high activation of DGAT.
本发明提供由式(Ie)和式(If)所表示的化合物,其中每个符号如规范中所定义。根据本发明,这些化合物具有DGAT抑制活性,并可用于预防、治疗或改善由DGAT高表达或高活化引起的疾病或病理学。